{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T01:42:03Z","timestamp":1769737323648,"version":"3.49.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T00:00:00Z","timestamp":1630368000000},"content-version":"am","delay-in-days":426,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.revmed.2020.05.014","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T01:49:45Z","timestamp":1594691385000},"page":"437-439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Beh\u00e7et's disease: The French recommendations"],"prefix":"10.1016","volume":"41","author":[{"given":"David","family":"Saadoun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.revmed.2020.05.014_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised international Chapel Hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2020.05.014_bb0010","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.3389\/fimmu.2019.01085","article-title":"Behcet\u2019s syndrome as a model of thrombo-inflammation: The role of neutrophils","volume":"10","author":"Emmi","year":"2019","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.revmed.2020.05.014_bb0015","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ng.624","article-title":"Genome-wide association studies identify IL23R-IL12RB2 and IL10 as behcet\u2019s disease susceptibility loci","volume":"42","author":"Mizuki","year":"2010","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.revmed.2020.05.014_bb0020","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ng.625","article-title":"Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with behcet\u2019s disease","volume":"42","author":"Remmers","year":"2010","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.revmed.2020.05.014_bb0025","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ng.2520","article-title":"Genome-wide association analysis identifies new susceptibility loci for behcet\u2019s disease and epistasis between HLA-B*51 and ERAP1","volume":"45","author":"Kirino","year":"2013","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.revmed.2020.05.014_bb0030","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jaci.2011.05.029","article-title":"Critical role of IL-21 in modulating TH17 and regulatory T cells in behcet\u2019s disease","volume":"128","author":"Geri","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.revmed.2020.05.014_bb0035","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1136\/annrheumdis-2018-214335","article-title":"Critical role of neutrophil extracellular traps (NETs) in patients with behcet\u2019s disease","volume":"78","author":"Le Joncour","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.revmed.2020.05.014_bb0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ng.2827","article-title":"A large-scale screen for coding variants predisposing to psoriasis","volume":"46","author":"Tang","year":"2014","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.revmed.2020.05.014_bb0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ng.733","article-title":"Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease","volume":"43","author":"Momozawa","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.revmed.2020.05.014_bb0050","doi-asserted-by":"crossref","unstructured":"Desbois AC, Vallet H, Domont F, Comarmond C, Cacoub P, Saadoun D: Management of severe complications in behcet's disease with TNF inhibitors. Expert Opin Biol Ther, 17(7):853\u2013859.","DOI":"10.1080\/14712598.2017.1328496"},{"issue":"4","key":"10.1016\/j.revmed.2020.05.014_bb0055","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1476-5381.2009.00559.x","article-title":"Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis","volume":"159","author":"Schafer","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.revmed.2020.05.014_bb0060","doi-asserted-by":"crossref","unstructured":"Hatemi G, Melikoglu M, Tunc R, Korkmaz C, Turgut Ozturk B, Mat C, Merkel PA, Calamia KT, Liu Z, Pineda L et al: Apremilast for behcet's syndrome--a phase 2, placebo-controlled study. N Engl J Med, 372(16):1510\u20131518.","DOI":"10.1056\/NEJMoa1408684"},{"issue":"20","key":"10.1016\/j.revmed.2020.05.014_bb0065","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1056\/NEJMoa1816594","article-title":"Trial of apremilast for oral ulcers in behcet\u2019s syndrome","volume":"381","author":"Hatemi","year":"2019","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.revmed.2020.05.014_bb0070","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.autrev.2013.02.002","article-title":"Biotherapies in inflammatory ocular disorders: Interferons, immunoglobulins","volume":"12","author":"Saadoun","year":"2013","journal-title":"monoclonal antibodies Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.revmed.2020.05.014_bb0075","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/ng.3459","article-title":"Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease","volume":"48","author":"Zhou","year":"2016","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.revmed.2020.05.014_bb0080","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/annrheumdis-2017-212403","article-title":"A20 haploinsufficiency (HA20): Clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease","volume":"77","author":"Aeschlimann","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.revmed.2020.05.014_bb0085","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.jaci.2017.10.039","article-title":"Haploinsufficiency of A20 causes autoinflammatory and autoimmune disorders","volume":"141","author":"Kadowaki","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.revmed.2020.05.014_bb0090","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1002\/art.34450","article-title":"Immunosuppressants reduce venous thrombosis relapse in behcet\u2019s disease","volume":"64","author":"Desbois","year":"2012","journal-title":"Arthritis Rheum"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866320302010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866320302010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:42:20Z","timestamp":1759336940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866320302010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0248866320302010"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2020.05.014","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beh\u00e7et's disease: The French recommendations","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2020.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}